3.16
+0.13(+4.29%)
Currency In USD
| Previous Close | 3.03 |
| Open | 3.15 |
| Day High | 3.22 |
| Day Low | 3.05 |
| 52-Week High | 6.47 |
| 52-Week Low | 2.01 |
| Volume | 18,709 |
| Average Volume | 49,325 |
| Market Cap | 7.09M |
| PE | -0.48 |
| EPS | -6.56 |
| Moving Average 50 Days | 2.79 |
| Moving Average 200 Days | 3.35 |
| Change | 0.13 |
If you invested $1000 in HeartSciences Inc. (HSCS) since IPO date, it would be worth $13.06 as of January 15, 2026 at a share price of $3.16. Whereas If you bought $1000 worth of HeartSciences Inc. (HSCS) shares 3 years ago, it would be worth $36.96 as of January 15, 2026 at a share price of $3.16.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire Inc.
Dec 15, 2025 9:15 PM GMT
Southlake, TX, Dec. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the integra
HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device
GlobeNewswire Inc.
Dec 15, 2025 1:30 PM GMT
Southlake, TX, Dec. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company advancing the use of ECG/EKGs through the integration of artificial i
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1
GlobeNewswire Inc.
Dec 11, 2025 1:30 PM GMT
Version 1.1 Designed to Provide Best Usability of any ECG SystemSouthlake, TX, Dec. 11, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company advanc